Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/284705 
Year of Publication: 
2024
Series/Report no.: 
SWP Comment No. 5/2024
Publisher: 
Stiftung Wissenschaft und Politik (SWP), Berlin
Abstract: 
The European Union's (EU) Global Health Strategy calls for open and strategic autonomy in the field of pharmaceuticals, which would lead to the redesign of EU global supply and value chains as well as trade relations. As the EU and Germany are seeking to diversify their trade partners, the Mercosur countries offer latent potential. Mercosur is the name of the South American trade bloc consisting of Argentina, Brazil, Paraguay and Uruguay, with Venezuela's membership currently suspended. The associate states of the bloc are Chile, Peru, Colombia, Ecuador, Guyana and Suriname. Bolivia is currently awaiting final approval to become a full member of the bloc.
Subjects: 
pharmaceutical supply chains
Mercosur countries
EU's Global Health Strategy
Argentina
Brazil
Paraguay
Uruguay
Chile
Peru
Colombia
Ecuador
Guyana
Suriname
Bolivia
free trade agreement (FTA)
European Medicines Agency (EMA)
Health Emergency Preparedness and Response Authority (HERA)
Persistent Identifier of the first edition: 
Document Type: 
Research Report

Files in This Item:
File
Size
418.31 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.